The Role of Chemotherapy in the Treatment of Adult Soft Tissue Sarcomas

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Oncology

• Publication date

  1999-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1159/000011924PMID 9885372
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Phase II trial of trimetrexate in patients with advanced soft-tissue sarcoma

  2004cited by this paper
• High-dose alkylation therapy using ifosfamide infusion with mesna in the treatment of adult advanced soft-tissue sarcoma

  2004cited by this paper
• A phase II trial of PALA+dipyridamole in patients with advanced soft-tissue sarcoma

  2004cited by this paper
• Hyperthermic antiblastic perfusion with alpha tumor necrosis factor and doxorubicin for the treatment of soft tissue limb sarcoma in candidates for amputation: results of a phase I study.

  1999cited by this paper
• Randomised study of high-dose epirubicin versus high-dose epirubicin-cisplatin chemotherapy for advanced soft tissue sarcoma.

  1997cited by this paper
• Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data. Sarcoma Meta-analysis Collaboration.

  1997cited by this paper
• High-dose ifosfamide: circumvention of resistance to standard-dose ifosfamide in advanced soft tissue sarcomas.

  1995cited by this paper
• Adjuvant therapy of soft-tissue sarcomas.

  1995cited by this paper
• 848 Docetaxel (taxotere) as first line therapy for metastatic or recurrent soft tissue sarcoma (STS): A phase II trial

  1995cited by this paper
• Doxorubicin versus CYVADIC versus doxorubicin plus ifosfamide in first-line treatment of advanced soft tissue sarcomas: a randomized study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.

  1995cited by this paper
• Phase II study of liposomal muramyl tripeptide phosphatidylethanolamine (MTP/PE) in advanced soft tissue sarcomas of the adult. An EORTC Soft Tissue and Bone Sarcoma Group study.

  1994cited by this paper
• Adjuvant CYVADIC chemotherapy for adult soft tissue sarcoma--reduced local recurrence but no improvement in survival: a study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.

  1994cited by this paper
• Cytotoxic drugs plus subcutaneous granulocyte-macrophage colony-stimulating factor: can molgramostim enhance antisarcoma therapy?

  1994cited by this paper
• Phase II study with Docetaxel (Taxotere®) in advanced soft tissue sarcomas of the adult

  1994cited by this paper
• Ifosfamide plus doxorubicin in previously untreated patients with advanced soft-tissue sarcoma.

  1993cited by this paper
• Edatrexate in patients with soft tissue sarcoma. Activity in malignant fibrous histiocytoma

  1993cited by this paper
• An intergroup phase III randomized study of doxorubicin and dacarbazine with or without ifosfamide and mesna in advanced soft tissue and bone sarcomas.

  1993cited by this paper
• Granulocyte-macrophage colony-stimulating factor allows safe escalation of dose-intensity of chemotherapy in metastatic adult soft tissue sarcomas: a study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.

  1993cited by this paper
• Chemotherapy in the multidisciplinary approach to soft tissue sarcomas. EORTC Soft Tissue and Bone Sarcoma Group studies in perspective.

  1992cited by this paper
• High dose chemotherapy with ABMT in soft tissue sarcomas: a report of 22 cases.

  1992cited by this paper
• An outpatient phase I study of a subcutaneous interleukin-2 and intramuscular alpha-2a-interferon combination in advanced malignancies.

  1992cited by this paper
• Short report: Phase II trials of trimetrexate in advanced adult soft tissue sarcomaStudies of the Canadian Sarcoma Group and the National Cancer Institute of Canada Clinical Trials Group

  1991cited by this paper
• Phase III comparison of doxorubicin and dacarbazine given by bolus versus infusion in patients with soft-tissue sarcomas: a Southwest Oncology Group study.

  1991cited by this paper
• High-dose DTIC in advanced soft-tissue sarcomas in the adult. A phase II study of the E.O.R.T.C. Soft Tissue and Bone Sarcoma Group.

  1991cited by this paper
• Phase II trials of trimetrexate in advanced adult soft tissue sarcoma. Studies of the Canadian Sarcoma Group and the National Cancer Institute of Canada Clinical Trials Group.

  1991cited by this paper
• Ifosfamide plus doxorubicin in previously untreated patients with advanced soft tissue sarcoma. The EORTC Soft Tissue and Bone Sarcoma Group.

  1990cited by this paper
• Randomized comparison of doxorubicin and vindesine to doxorubicin for patients with metastatic soft‐tissue sarcomas

  1990cited by this paper
• Phase II Trial of Carboplatin in Soft‐Tissue Sarcoma

  1990cited by this paper
• Response to mesna, doxorubicin, ifosfamide, and dacarbazine in 108 patients with metastatic or unresectable sarcoma and no prior chemotherapy.

  1989cited by this paper
• Adjuvant chemotherapy with doxorubicin in high-grade soft tissue sarcoma: a randomized trial of the Scandinavian Sarcoma Group.

  1989cited by this paper
• A phase I-II study of ifosfamide in combination with adriamycin in the treatment of adult soft tissue sarcoma.

  1988cited by this paper
• A Randomized Prospective Trial Using Postoperative Adjuvant Chemotherapy (Adriamycin) in High‐Grade Extremity Soft‐Tissue Sarcoma

  1988cited by this paper
• Adjuvant chemotherapy for patients with high-grade soft-tissue sarcomas of the extremity.

  1988cited by this paper
• Adjuvant Therapy for Soft Tissue Sarcomas

  1988cited by this paper
• Cyclophosphamide versus ifosfamide: final report of a randomized phase II trial in adult soft tissue sarcomas.

  1987cited by this paper
• Adriamycin versus epirubicin in advanced soft tissue sarcomas. A randomized phase II/phase III study of the EORTC Soft Tissue and Bone Sarcoma Group.

  1987cited by this paper
• Fludarabine Phosphate Phase II Evaluation in Advanced Soft‐Tissue Sarcomas

  1987cited by this paper
• A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone.

  1987cited by this paper
• Combination chemotherapy using adriamycin, DTIC, cyclophosphamide, and actinomycin D for advanced soft tissue sarcomas: a randomized comparative trial. A phase III, Southwest Oncology Group Study (7613).

  1987cited by this paper
• Randomized comparison of three adriamycin regimens for metastatic soft tissue sarcomas.

  1987cited by this paper
• A randomized trial for the treatment of high-grade soft-tissue sarcomas of the extremities: preliminary observations.

  1986cited by this paper
• Doxorubicin, ifosfamide, and dacarbazine (AID) with mesna uroprotection for advanced untreated sarcoma: a phase I study.

  1986cited by this paper
• Doxorubicin chemotherapy in the treatment of soft-tissue sarcoma. Combined results of two randomized trials.

  1986cited by this paper
• A randomized clinical trial of adjuvant adriamycin in uterine sarcomas: a Gynecologic Oncology Group Study.

  1985cited by this paper
• A randomized, prospective trial of adjuvant chemotherapy in adults with soft tissue sarcomas of the head and neck, breast, and trunk

  1985cited by this paper
• Phase II evaluation of PALA in patients with refractory metastatic sarcomas

  1984cited by this paper
• Cyvadic in advanced soft tissue sarcoma: A randomized study comparing two schedules: A study of the EORTC soft tissue and bone sarcoma group

  1984cited by this paper
• Randomized study of systemic chemotherapy following complete excision of nonosseous sarcomas.

  1984cited by this paper
• Infusion Chemotherapy for Soft Tissue Sarcomas

  1983cited by this paper
• Carminomycin vs adriamycin in advanced soft tissue sarcomas: an EORTC randomised phase II study.

  1983cited by this paper
• A one-day combination chemotherapy (CYVADIC) regimen in soft tissue sarcomas

  1982cited by this paper
• A comparison of adriamycin versus vincristine and adriamycin, and cyclophosphamide versus vincristine, actinomycin‐D, and cyclophosphamide for advanced sarcoma

  1982cited by this paper
• Protected environment–Prophylactic antibiotic program for malignant sarcomas: Randomized trial during remission induction chemotherapy

  1981cited by this paper
• Clinical trial of VP 16–213 (NSC 141540) I.V. Twice weekly in advanced neoplastic disease a study by the cancer and leukemia group B

  1980cited by this paper
• Cyclophosphamide, vincristine, adriamycin, and DTIC (CYVADIC) combination chemotherapy for the treatment of advanced sarcomas.

  1980cited by this paper
• Cis-dichlorodiammineplatinum(II) in metastatic soft tissue sarcomas.

  1979cited by this paper
• Survival and relapse patterns of complete responders in adults with advanced soft tissue sarcomas (ASTS)

  1979cited by this paper
• Chemotherapy of advanced soft-tissue sarcomas in adults.

  1977cited by this paper
• Dose response evaluation of adriamycin in human neoplasia

  1977cited by this paper
• A comparative clinical trial evaluating the combination of adriamycin, DTIC, and vincristine, the combination of actinomycin D, cyclophosphamide, and vincristine, and a single agent, methyl-CCNU, in advanced sarcomas.

  1976cited by this paper
• Role of DTIC (NSC-45388) in the chemotherapy of sarcomas.

  1976cited by this paper
• Proceedings: Combination chemotherapy for metastatic sarcoma.

  1974cited by this paper
• Phase II evaluation of adriamycin in human neoplasia

  1973cited by this paper
• Chemotherapy of sarcomas with a combination of adriamycin and dimethyl triazeno imidazole carboxamide

  1972cited by this paper
• Combination phase 1-II study of imidazole carboxamide (NCS45388).

  1972cited by this paper
• Sarcomas of Soft Tissues: Chairman's Address

  1963cited by this paper
• Sarcomas of soft tissues.

  1963cited by this paper

• Dual-Action Therapeutics: DNA Alkylation and Antimicrobial Peptides for Cancer Therapy

  2024cites this paper
• Complete remission of a case of high-grade myxofibrosarcoma with lung metastases after modified MAID regimen chemotherapy

  2020cites this paper
• A Case of Primary Cardiac Angiosarcoma Presenting with Hemorrhagic Pleural and Pericardial Effusions in a Young Woman

  2018cites this paper
• Chapitre 42 – Tumeurs malignes de l'aorte et de ses branches

  2016cites this paper
• Combination of Cisplatin, Ifosfamide, and Adriamycin as Neoadjuvant Chemotherapy for Extremity Soft Tissue Sarcoma

  2016cites this paper
• Randomised phase III trial of trabectedin versus doxorubicin-based chemotherapy as first-line therapy in translocation-related sarcomas.

  2014cites this paper
• Diagnostic dilemma of cardiac synovial sarcoma – Primary or secondary

  2013cites this paper
• Alter und Subtyp beeinflussen die Behandlungsstrategie

  2013cites this paper
• Cardiac angiosarcoma in a pregnant woman: a case report and review of the literature

  2012cites this paper
• Clinical and pharmacokinetic evaluation of trabectedin for the treatment of soft-tissue sarcoma

  2012cites this paper
• Chapitre 22 – Tumeurs Malignes Vasculaires

  2011cites this paper
• Primary cardiac synovial sarcoma

  2010cites this paper
• Primary Cardiac Angiosarcoma in a Young Woman

  2010cites this paper
• Transient Global Amnesia as the Presenting Feature of Heparin‐Induced Thrombocytopenia

  2010cites this paper
• Detachment of an Annular Patch Following the Manougian Procedure

  2010cites this paper
• Massive Right Atrial Myxoma Causing Right Ventricular Inflow Obstruction: An Unusual Presentation of Myxoma

  2010cites this paper
• Delayed Presentation of Iatrogenic Left Ventricular Pseudoaneurysm

  2010cites this paper
• Mapping the literature: role of trabectedin as a new chemotherapy option in advanced pretreated soft tissue sarcoma.

  2009cites this paper
• Identification and validation of therapeutic targets in sarcoma models

  2009cites this paper
• A Case of Primary Cardiac Angiosarcoma: Extensive Right Atrial Wall Reconstruction with Autologous Pericardium

  2009cites this paper
• Phase I clinical and pharmacokinetic study of trabectedin and doxorubicin in advanced soft tissue sarcoma and breast cancer.

  2009cites this paper
• Soft tissue sarcomas of the extremities: How to stay out of trouble

  2008cites this paper
• SYMPOSIUM: MOLECULAR GENETICS IN SARCOMA

  2008cites this paper
• Synovial Sarcoma: From Genetics to Genetic-based Animal Modeling

  2008cites this paper
• Extreme sensitivity to Yondelis® (Trabectedin, ET‐743) in low passaged sarcoma cell lines correlates with mutated p53

  2007cites this paper
• Zasady leczenia chorych na mięsaki tkanek miękkich kończyn

  2007cites this paper
• Kapitel 26 – Solide Tumoren

  2007cites this paper
• Histamine’s vasoactive properties improving response rates in solid tumor treatment

  2006cites this paper
• Histamine, a vasoactive agent with vascular disrupting potential, improves tumour response by enhancing local drug delivery

  2006cites this paper
• Ifosfamide. Metabolic studies, new therapeutic approaches and new analogs.

  2006cites this paper
• Phase 1 European Organisation for Research and Treatment of Cancer study determining safety of pegylated liposomal doxorubicin (Caelyx) in combination with ifosfamide in previously untreated adult patients with advanced or metastatic soft tissue sarcomas.

  2006cites this paper
• In Vitro Chemosensitivity Test of Human Soft Tissue Sarcoma Using the HDRA(Histoculture Drug Response Assay) Method

  2005cites this paper
• Diagnosis and Management of Synovial Sarcoma

  2005influential citation
• ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of soft tissue sarcomas.

  2005cites this paper
• Therapy Regimens Used in Adjuvant and Neoadjuvant Treatment of the Discussed Tumor Types

  2005cites this paper
• Ifosfamide, carboplatin and etoposide (ICE) as second-line regimen alone and in combination with regional hyperthermia is active in chemo-pre-treated advanced soft tissue sarcoma of adults

  2004cites this paper
• Emerging treatments for soft tissue sarcoma of adults

  2004influential citation
• Synthesis of potential metabolites of (S)-(-)-bromofosfamide.

  2004cites this paper
• The Role of Chemotherapy in the Treatment of Bone and Soft-tissue Sarcomas

  2004cites this paper
• Analysis of the Urinary Excretion of Ifosfamide and its N-Dechloroethylated Metabolites in Children Using 31P-NMR Spectroscopy

  2003cites this paper
• Unusual Response to Second-Line Single-Agent Gemcitabine in Locally Advanced Primary Leiomyosarcoma of the Lung: A Case Report

  2003cites this paper
• Metastatic Soft Tissue Sarcoma in Adults

  2003cites this paper
• Role of systemic treatment in adult soft tissue sarcomas

  2003cites this paper
• Gynaecology Retrospective Study of Management of Uterine Sarcomas at Oxford 1990-1998: Role of Adjuvant Treatment

  2002cites this paper
• New and evolving treatment methods for pulmonary metastases.

  2002cites this paper
• Retrospective study of management of uterine sarcomas at Oxford 1990-1998: role of adjuvant treatment.

  2002cites this paper
• Studies on the side-chain hydroxylation of ifosfamide and its bromo analogue.

  2002cites this paper
• Gemcitabine in advanced adult soft-tissue sarcomas. A phase II study of the EORTC Soft Tissue and Bone Sarcoma Group.

  2002cites this paper
• (S)-(−)-Bromofosfamide (CBM-11): synthesis and antitumor activity and toxicity in mice

  2001cites this paper
• In vitro chemosensitivity of human soft tissue sarcoma.

  2001cites this paper
• Adjuvant chemotherapy for extremity soft-tissue sarcomas in adults

  2000cites this paper
• Treatment of advanced soft tissue sarcomas with ifosfamide and doxorubicin combination chemotherapy

  2000cites this paper
• Role of the Combination of Ifosfamide and Etoposide in the Treatment of Soft Tissue Sarcomas

  1999cites this paper
• Seltene Tumoren der Bauchhöhle

  1999cites this paper
• Primary Cardiac Synovial Sarcoma: A Case Report and Brief Review of the Literature

  1996cites this paper
• Seminarios de la Fundación Española de Reumatología

  year unknowncites this paper